Headquarters
UNIT 4, 117 BROADWAY, NEDLANDS, WA 6009, AU
NEDLANDS, WA, AU
ARGENICA THERAPEUTICS LIMITED
From the company
Argenica Therapeutics Limited (ASX:AGN) is a clinical stage drug development company developing novel neuroprotective therapeutics to reduce brain damage after stroke and other acute brain injuries. Its lead candidate ARG-007, a cationic arginine-rich peptide, is based on research from The University of Western Australia and the Perron Institute for Neurological and Translational Science. ARG-007 has completed a Phase 1 clinical trial and is being tested in a Phase 2 clinical trial in acute ischaemic stroke patients in Australia.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.